Lpl Financial LLC Blueprint Medicines Corp Transaction History

Lpl Financial LLC

$218 Billion
Q3 2024

A detailed history of Lpl Financial LLC transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Lpl Financial LLC holds 9,081 shares of BPMC stock, worth $821,467. This represents 0.0% of its overall portfolio holdings.

Number of Shares

9,081

Previous 9,233 1.65%

Holding current value

$821,467

Previous $995,000 15.68%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$84.1 - $120.5 $12,783 - $18,316	-152 Reduced 1.65%	9,081 $839,000
Q2 2024 Aug 07, 2024	SELL	$85.18 - $108.78 $30,068 - $38,399	-353 Reduced 3.68%	9,233 $995,000
Q1 2024 May 10, 2024	BUY	$73.17 - $99.79 $15,804 - $21,554	216 Added 2.31%	9,586 $909,000
Q4 2023 Feb 14, 2024	SELL	$43.96 - $92.84 $62,599 - $132,204	-1,424 Reduced 13.19%	9,370 $864,000
Q3 2023 Nov 13, 2023	SELL	$46.9 - $66.0 $6,659 - $9,372	-142 Reduced 1.3%	10,794 $542,000
Q2 2023 Jul 31, 2023	BUY	$42.2 - $66.37 $10,803 - $16,990	256 Added 2.4%	10,936 $691,000
Q1 2023 May 10, 2023	BUY	$37.97 - $50.0 $80,648 - $106,200	2,124 Added 24.82%	10,680 $480,000
Q4 2022 Feb 07, 2023	BUY	$41.06 - $66.48 $156,438 - $253,288	3,810 Added 80.28%	8,556 $374,000
Q3 2022 Nov 14, 2022	BUY	$49.93 - $77.7 $236,967 - $368,764	4,746 New	4,746 $313,000
Q1 2022 May 16, 2022	SELL	$54.1 - $110.08 $126,972 - $258,357	-2,347 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$94.25 - $115.99 $1,790 - $2,203	19 Added 0.82%	2,347 $251,000
Q3 2021 Nov 15, 2021	BUY	$80.98 - $109.47 $188,521 - $254,846	2,328 New	2,328 $239,000
Q2 2021 Aug 13, 2021	SELL	$82.78 - $101.0 $1.56 Million - $1.9 Million	-18,809 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$90.71 - $108.28 $1.45 Million - $1.73 Million	16,006 Added 571.03%	18,809 $1.83 Million
Q4 2020 Feb 12, 2021	SELL	$92.08 - $124.48 $53,498 - $72,322	-581 Reduced 17.17%	2,803 $314,000
Q3 2020 Nov 09, 2020	BUY	$66.45 - $92.7 $30,301 - $42,271	456 Added 15.57%	3,384 $314,000
Q2 2020 Aug 13, 2020	BUY	$57.09 - $79.27 $167,159 - $232,102	2,928 New	2,928 $228,000
Q1 2020 May 14, 2020	SELL	$48.11 - $82.22 $164,921 - $281,850	-3,428 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$66.73 - $82.59 $14,747 - $18,252	221 Added 6.89%	3,428 $275,000
Q3 2019 Nov 13, 2019	SELL	$72.9 - $101.41 $481,358 - $669,610	-6,603 Reduced 67.31%	3,207 $236,000
Q2 2019 Aug 09, 2019	BUY	$73.54 - $97.8 $439,769 - $584,844	5,980 Added 156.14%	9,810 $925,000
Q1 2019 May 08, 2019	BUY	$48.7 - $86.6 $186,521 - $331,678	3,830 New	3,830 $307,000
Q4 2018 Feb 07, 2019	SELL	$45.57 - $74.26 $239,789 - $390,756	-5,262 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$58.91 - $78.32 $309,984 - $412,119	5,262 New	5,262 $411,000

Others Institutions Holding BPMC

# of Institutions

351

Shares Held

60.3M

Call Options Held

2.25M

Put Options Held

1.18M

View Full List

About Blueprint Medicines Corp

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $5.4B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

More about BPMC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.

Account

Lpl Financial LLC Blueprint Medicines Corp Transaction History